Онлайн книга «Кривое зеркало жизни. Главные мифы о раке, и что современная наука думает о них»
|
Nelson C. M., Bissell M. J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer // Annual Review of Cell and Developmental Biology, 2006, 22, 287–309. Pachmayr E., Treese C., Stein U. Underlying Mechanisms for Distant Metastasis — Molecular Biology // Visceral Medicine, 2017, 33 (1), 11–20. Peinado H., Lavotshkin S., Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts // Seminars in Cancer Biology, 2011, 21 (2), 139–146. Rich R. M., Rosenfeld P. J., Puliafito C. A., Dubovy S. R. & others. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration // Retina, 2006, 26 (5), 495–511. Yang J., Weinberg R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis // Developmental Cell, 2008, 14 (6), 818–829. Глава 7. Тонкости распознавания «свой-чужой» и мифы об иммунитете Терапевтические антитела. Спецпроект электронного журнала «Биомолекула». https://biomolecula.ru/specials/antitela. Ярилин А. А. Иммунология. — М.: ГЭОТАР-Медиа, 2010. Blum J. S., Wearsch P. A., Cresswell P. Pathways of antigen processing // Annual Review of Immunology, 2013, 31, 443–473. Bottazzi B., Riboli E., Mantovani A. Aging, inflammation and cancer // Seminars in Immunology, 2018, 40, 74–82. June C. H., O’Connor R. S., Kawalekar O. U., Ghassemi S., Milone M. C. CAR T cell immunotherapy for human cancer // Science, 2018, 359 (6382), 1361–1365. Kucerova P., Cervinkova M. Spontaneous regression of tumour and the role of microbial infection — possibilities for cancer treatment // Anticancer Drugs, 2016, 27 (4), 269–277. Liu J. K. The history of monoclonal antibody development — Progress, remaining challenges and future innovations // Annals of Medicine and Surgery (Lond), 2014, 3 (4), 113–116. Mantovani A., Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity // Current Opinion in Immunology, 2010, 22 (2), 231–237. Murchison E. P. Clonally transmissible cancers in dogs and Tasmanian devils // Oncogene, 2008, 27, 19–30. Papac R. J. Spontaneous regression of cancer // Cancer Treatment Reviews, 1996, 22 (6), 395–423. Murgia C., Pritchard J. K., Kim S. Y., Fassati A., Weiss R. A. Clonal origin and evolution of a transmissible cancer // Cell, 2006, 126 (3), 477–487. Pardoll D. M. The blockade of immune checkpoints in cancer immunotherapy // Nature Reviews Cancer, 2012, 12 (4), 252–264. Rashidi A., Fisher S. I. Spontaneous remission of acute myeloid leukemia // Leukemia & Lymphoma, 2015, 56 (6), 1727–1734. Reeves E., James E. Antigen processing and immune regulation in the response to tumours // Immunology, 2017, 150 (1), 16–24. Schreiber R. D., Old L. J., Smyth M. J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion // Science, 2011, 331 (6024), 1565–1570. Syn N. L., Teng M. W. L., Mok T. S. K., Soo R. A. De-novo and acquired resistance to immune checkpoint targeting // The Lancet Oncology, 2017, 18 (12), e731 — e741. Vesely M. D., Kershaw M. H., Schreiber R. D., Smyth M. J. Natural innate and adaptive immunity to cancer // Annual Review Of Immunology, 2011, 29, 235–271. Глава 8. Дивный новый мир молекулярной онкологии и мифы о заговоре в медицине Barabasi A. L., Oltvai Z. N. Network biology: understanding the cell's functional organization // Nature Reviews Genetics, 2004, 5 (2), 101–113. Evidence-based medicine. https://en.wikipedia.org/wiki/Evidence-based_medicine. Hood L., Friend S. H. Predictive, personalized, preventive, participatory (P4) cancer medicine // Nature Reviews Clinical Oncology, 2011, 8 (3), 184–187. Kaitin K. I. Deconstructing the drug development process: the new face of innovation // Clinical Pharmacology & Therapeutics, 2010, 87 (3), 356–361. Luo J., Wu M., Gopukumar D., Zhao Y. Big Data Application in Biomedical Research and Health Care: A Literature Review // Biomedical Informatics Insights, 2016, 8, 1–10. Masic I., Miokovic M., Muhamedagic B. Evidence based medicine — new approaches and challenges // Acta Informatica Medica, 2008, 16 (4), 219–225. Sackett D. L., Rosenberg W. M., Gray J. A., Haynes R. B., Richardson W. S. Evidence based medicine: what it is and what it isn’t // British Medical Journal, 1996, 312 (7023), 71–72. The Drug Development Process (FDA). https://www.fda.gov/forpatients/approvals/drugs/. Umar A., Dunn B. K., Greenwald P. Future directions in cancer prevention // Nature Reviews Cancer, 2012, 12 (12), 835–848. Послесловие. Не наукой единой… Лэнгле А. Жизнь, наполненная смыслом. Прикладная логотерапия. — М.: Генезис, 2017. Франкл В. Человек в поисках смысла. — М.: Прогресс, 1990. |